Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Rosemary extracts with carnosic acid and carnosol can reduce the harmfulness of Staphylococcus aureus without stopping its growth.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Applying certain inhibitors to the skin can promote hair growth without harming cells.

Cell polarity signaling controls tissue mechanics and cell fate, with complex interactions and varying pathways across species.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Storing hair follicles in a special buffer with certain inhibitors can increase hair growth and improve transplant results.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

The compounds tested could potentially treat hair loss and alopecia.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Blocking JAK-STAT signaling can lead to hair growth.

Some common medications can harm male fertility, but many effects can be reversed.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

Minoxidil slows down skin cell growth and may help treat scars and skin conditions.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.